Skip to main content
Journal cover image

Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

Publication ,  Conference
Bomback, AS; Appel, GB; Gipson, DS; Hladunewich, MA; Lafayette, R; Nester, CM; Parikh, SV; Smith, RJH; Trachtman, H; Heeger, PS; Ram, S ...
Published in: Am J Kidney Dis
April 2022

Blocking the complement system as a therapeutic strategy has been proposed for numerous glomerular diseases but presents myriad questions and challenges, not the least of which is demonstrating efficacy and safety. In light of these potential issues and because there are an increasing number of anticomplement therapy trials either planned or under way, the National Kidney Foundation facilitated an all-virtual scientific workshop entitled "Improving Clinical Trials for Anti-Complement Therapies in Complement-Mediated Glomerulopathies." Attended by patient representatives and experts in glomerular diseases, complement physiology, and clinical trial design, the aim of this workshop was to develop standards applicable for designing and conducting clinical trials for anticomplement therapies across a wide spectrum of complement-mediated glomerulopathies. Discussions focused on study design, participant risk assessment and mitigation, laboratory measurements and biomarkers to support these studies, and identification of optimal outcome measures to detect benefit, specifically for trials in complement-mediated diseases. This report summarizes the discussions from this workshop and outlines consensus recommendations.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Kidney Dis

DOI

EISSN

1523-6838

Publication Date

April 2022

Volume

79

Issue

4

Start / End Page

570 / 581

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Kidney Diseases
  • Kidney
  • Humans
  • Complement System Proteins
  • Complement Inactivator Proteins
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bomback, A. S., Appel, G. B., Gipson, D. S., Hladunewich, M. A., Lafayette, R., Nester, C. M., … Thurman, J. M. (2022). Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. In Am J Kidney Dis (Vol. 79, pp. 570–581). United States. https://doi.org/10.1053/j.ajkd.2021.07.025
Bomback, Andrew S., Gerald B. Appel, Debbie S. Gipson, Michelle A. Hladunewich, Richard Lafayette, Carla M. Nester, Samir V. Parikh, et al. “Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.” In Am J Kidney Dis, 79:570–81, 2022. https://doi.org/10.1053/j.ajkd.2021.07.025.
Bomback AS, Appel GB, Gipson DS, Hladunewich MA, Lafayette R, Nester CM, et al. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. In: Am J Kidney Dis. 2022. p. 570–81.
Bomback, Andrew S., et al. “Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.Am J Kidney Dis, vol. 79, no. 4, 2022, pp. 570–81. Pubmed, doi:10.1053/j.ajkd.2021.07.025.
Bomback AS, Appel GB, Gipson DS, Hladunewich MA, Lafayette R, Nester CM, Parikh SV, Smith RJH, Trachtman H, Heeger PS, Ram S, Rovin BH, Ali S, Arceneaux N, Ashoor I, Bailey-Wickins L, Barratt J, Beck L, Cattran DC, Cravedi P, Erkan E, Fervenza F, Frazer-Abel AA, Fremeaux-Bacchi V, Fuller L, Gbadegesin R, Hogan JJ, Kiryluk K, le Quintrec-Donnette M, Licht C, Mahan JD, Pickering MC, Quigg R, Rheault M, Ronco P, Sarwal MM, Sethna C, Spino C, Stegall M, Vivarelli M, Feldman DL, Thurman JM. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2022. p. 570–581.
Journal cover image

Published In

Am J Kidney Dis

DOI

EISSN

1523-6838

Publication Date

April 2022

Volume

79

Issue

4

Start / End Page

570 / 581

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Kidney Diseases
  • Kidney
  • Humans
  • Complement System Proteins
  • Complement Inactivator Proteins
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences